BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 8411352)

  • 1. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
    Bennett RP; Nelle TD; Wills JW
    J Virol; 1993 Nov; 67(11):6487-98. PubMed ID: 8411352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release.
    Weldon RA; Wills JW
    J Virol; 1993 Sep; 67(9):5550-61. PubMed ID: 8394460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.
    Bowzard JB; Bennett RP; Krishna NK; Ernst SM; Rein A; Wills JW
    J Virol; 1998 Nov; 72(11):9034-44. PubMed ID: 9765448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly.
    Bennett RP; Rhee S; Craven RC; Hunter E; Wills JW
    J Virol; 1991 Jan; 65(1):272-80. PubMed ID: 1845888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
    Campbell S; Vogt VM
    J Virol; 1995 Oct; 69(10):6487-97. PubMed ID: 7666550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein.
    Parent LJ; Wilson CB; Resh MD; Wills JW
    J Virol; 1996 Feb; 70(2):1016-26. PubMed ID: 8551559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.
    Xiang Y; Ridky TW; Krishna NK; Leis J
    J Virol; 1997 Mar; 71(3):2083-91. PubMed ID: 9032340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.
    Johnson MC; Spidel JL; Ako-Adjei D; Wills JW; Vogt VM
    J Virol; 2005 Mar; 79(6):3775-86. PubMed ID: 15731271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport and processing of the Rous sarcoma virus Gag protein in the endoplasmic reticulum.
    Krishna NK; Weldon RA; Wills JW
    J Virol; 1996 Mar; 70(3):1570-9. PubMed ID: 8627676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src.
    Wills JW; Craven RC; Weldon RA; Nelle TD; Erdie CR
    J Virol; 1991 Jul; 65(7):3804-12. PubMed ID: 1710290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The membrane-binding domain of the Rous sarcoma virus Gag protein.
    Verderame MF; Nelle TD; Wills JW
    J Virol; 1996 Apr; 70(4):2664-8. PubMed ID: 8642704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of Rous sarcoma virus particle size.
    Krishna NK; Campbell S; Vogt VM; Wills JW
    J Virol; 1998 Jan; 72(1):564-77. PubMed ID: 9420260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101.
    Medina G; Zhang Y; Tang Y; Gottwein E; Vana ML; Bouamr F; Leis J; Carter CA
    Traffic; 2005 Oct; 6(10):880-94. PubMed ID: 16138902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assembly domain of the Rous sarcoma virus Gag protein required late in budding.
    Wills JW; Cameron CE; Wilson CB; Xiang Y; Bennett RP; Leis J
    J Virol; 1994 Oct; 68(10):6605-18. PubMed ID: 8083996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein.
    Puffer BA; Parent LJ; Wills JW; Montelaro RC
    J Virol; 1997 Sep; 71(9):6541-6. PubMed ID: 9261374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.
    Parent LJ; Bennett RP; Craven RC; Nelle TD; Krishna NK; Bowzard JB; Wilson CB; Puffer BA; Montelaro RC; Wills JW
    J Virol; 1995 Sep; 69(9):5455-60. PubMed ID: 7636991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.
    Keller PW; Johnson MC; Vogt VM
    J Virol; 2008 Jul; 82(14):6788-97. PubMed ID: 18448521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.
    Campbell S; Vogt VM
    J Virol; 1997 Jun; 71(6):4425-35. PubMed ID: 9151833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.
    Bowzard JB; Visalli RJ; Wilson CB; Loomis JS; Callahan EM; Courtney RJ; Wills JW
    J Virol; 2000 Sep; 74(18):8692-9. PubMed ID: 10954570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain.
    Xiang Y; Cameron CE; Wills JW; Leis J
    J Virol; 1996 Aug; 70(8):5695-700. PubMed ID: 8764091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.